Novel Biomarkers to Guide Immunotherapy De-Escalation in the Neoadjuvant Setting in Triple-Negative Breast Cancer

J Pers Med. 2023 Aug 27;13(9):1313. doi: 10.3390/jpm13091313.

Abstract

Triple-negative breast cancer (TNBC) has the highest incidence of disease recurrence and distant metastases among breast cancer subtypes, leading to significant rates of morbidity and mortality [...].

Publication types

  • Editorial